Ionis to present at TD Cowen Genetic Medicines & RNA Summit

Company Overview - Ionis Pharmaceuticals has been innovating medicines for over three decades, focusing on serious diseases [3] - The company currently markets five medicines and has a strong pipeline in neurology, cardiology, and other high-need areas [3] - Ionis is a pioneer in RNA-targeted medicines and is advancing new approaches in gene editing [3] Upcoming Events - Ionis management will participate in a fireside chat at the virtual TD Cowen Genetic Medicines & RNA Summit on June 20, 2024 [1] - A live webcast of the presentation will be available on the Ionis website, with a replay accessible within 48 hours [2]